1 |
Smith RK, Carroll PM, Allard JD and Simon MA (2002) MASK, a large ankyrin repeat and KH domain-containing protein involved in Drosophila receptor tyrosine kinase signaling. Development 129, 71-82
DOI
|
2 |
Li J, Mahajan A and Tsai MD (2006) Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45, 15168-15178
DOI
|
3 |
Islam Z, Nagampalli RSK, Fatima MT and Ashraf GM (2018) New paradigm in ankyrin repeats: Beyond proteinprotein interaction module. Int J Biol Macromol 109, 1164-1173
DOI
|
4 |
Sedgwick SG and Smerdon SJ (1999) The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 24, 311-316
DOI
|
5 |
Mosavi LK, Cammett TJ, Desrosiers DC and Peng ZY (2004) The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 13, 1435-1448
DOI
|
6 |
Hollenbeck JJ, Danner DJ, Landgren RM, Rainbolt TK and Roberts DS (2012) Designed ankyrin repeat proteins as scaffolds for multivalent recognition. Biomacromolecules 13, 1996-2002
DOI
|
7 |
Valverde R, Edwards L and Regan L (2008) Structure and function of KH domains. FEBS J 275, 2712-2726
DOI
|
8 |
Nazarov IB, Bakhmet EI and Tomilin AN (2019) KHDomain poly(C)-binding proteins as versatile regulators of multiple biological processes. Biochemistry (Mosc) 84, 205-219
DOI
|
9 |
Nicastro G, Taylor IA and Ramos A (2015) KH-RNA interactions: back in the groove. Curr Opin Struct Biol 30, 63-70
DOI
|
10 |
Fragiadaki M and Zeidler MP (2018) Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs. J Biol Chem 293, 9570-9579
DOI
|
11 |
Yang C, Zheng J, Liu X et al (2020) Role of ANKHD1/LINC00346/ZNF655 feedback loop in regulating the glioma angiogenesis via staufen1-mediated mRNA decay. Mol Ther Nucleic Acids 20, 866-878
DOI
|
12 |
Sidor C, Borreguero-Munoz N, Fletcher GC, Elbediwy A, Guillermin O and Thompson BJ (2019) Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability. Elife 8, e48601
DOI
|
13 |
Miles MC, Janket ML, Wheeler ED et al (2005) Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis. FEBS J 272, 4091-4102
DOI
|
14 |
Santos Duarte Ada S, Traina F, Favaro PM et al (2005) Characterisation of a new splice variant of MASK-BP3(ARF) and MASK human genes, and their expression patterns during haematopoietic cell differentiation. Gene 363, 113-122
DOI
|
15 |
Traina F, Favaro PM, Medina Sde S et al (2006) ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells. Biochim Biophys Acta 1762, 828-834
DOI
|
16 |
Muller P, Kuttenkeuler D, Gesellchen V, Zeidler MP and Boutros M (2005) Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 436, 871-875
DOI
|
17 |
Sansores-Garcia L, Atkins M, Moya IM et al (2013) Mask is required for the activity of the Hippo pathway effector Yki/YAP. Curr Biol 23, 229-235
DOI
|
18 |
Fisher KH, Fragiadaki M, Pugazhendhi D et al (2018) A genome-wide RNAi screen identifies MASK as a positive regulator of cytokine receptor stability. J Cell Sci 131, jcs209551
DOI
|
19 |
Patera F, Hautbergue GM, Wilson P, Evans PC, Ong AC and Fragiadaki M (2020) Ankhd1 enhances polycystic kidney disease development via promoting proliferation and fibrosis, bioRxiv (https://doi.org/10.1101/2020.03.04.977017)
|
20 |
Sidor CM, Brain R and Thompson BJ (2013) Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr Biol 23, 223-228
DOI
|
21 |
Du Toit A (2013) Cell signalling: A new Hippo pathway component. Nat Rev Mol Cell Biol 14, 196
DOI
|
22 |
Machado-Neto JA, Lazarini M, Favaro P et al (2014) ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Exp Cell Res 324, 137-145
DOI
|
23 |
Yao P, Li Y, Shen W et al (2018) ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT. Am J Cancer Res 8, 2311-2324
|
24 |
Liu X-F, Han Q, Rong X-Z et al (2020) ANKHD1 promotes proliferation and invasion of non-small-cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Int J Oncol 56, 1175-1185
|
25 |
Machado-Neto JA, Lazarini M, Favaro P et al (2015) ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta 1853, 583-593
DOI
|
26 |
Yu FX, Zhao B and Guan KL (2015) Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811-828
DOI
|
27 |
Machado-Neto JA, de Melo Campos P, Favaro P et al (2014) Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leuk Res 38, 251-257
DOI
|
28 |
Machado-Neto JA, Saad ST and Traina F (2014) Stathmin 1 in normal and malignant hematopoiesis. BMB Rep 47, 660-665
DOI
|
29 |
Dhyani A, Duarte AS, Machado-Neto JA, Favaro P, Ortega MM and Olalla Saad ST (2012) ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. FEBS Lett 586, 4311-4318
DOI
|
30 |
Dhyani A, Machado-Neto JA, Favaro P and Saad ST (2015) ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth. Eur J Cancer 51, 252-259
DOI
|
31 |
Dhyani A, Favaro P and Saad STO (2020) ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells. Blood Cells Mol Dis 84, 102460
DOI
|
32 |
Zhou Z, Jiang H, Tu K et al (2019) ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 38, 18
DOI
|
33 |
Zhu M, Li X, Tian X and Wu C (2015) Mask loss-offunction rescues mitochondrial impairment and muscle degeneration of Drosophila pink1 and parkin mutants. Hum Mol Genet 24, 3272-3285
DOI
|
34 |
Kitamata M, Hanawa-Suetsugu K, Maruyama K and Suetsugu S (2019) Membrane-deformation ability of ANKHD1 is involved in the early endosome enlargement. iScience 17, 101-118
DOI
|
35 |
Hou SC, Chan LW, Chou YC et al (2009) Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis. FEBS Lett 583, 2765-2771
DOI
|